Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Ng

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Human Gene Therapy|February 18, 2004
Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primatesNicola Brunetti-Pierri, Donna J Palmer, Arthur L Beaudet, et al.
Human Gene Therapy|November 26, 2008
Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapySean E Hofherr, Julien S Senac, Christopher Y Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Viral vector-mediated and cell-based therapies for treatment of cystic fibrosisTerence R Flotte, Philip Ng, Doug E Dylla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
Fully deleted adenovirus persistently expressing GAA accomplishes long-term skeletal muscle glycogen correction in tolerant and nontolerant GSD-II miceAnne Kiang, Zachary C Hartman, Shaoxi Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2013
SR-A and SREC-I are Kupffer and endothelial cell receptors for helper-dependent adenoviral vectorsPasquale Piccolo, Francesco Vetrini, Pratibha Mithbaokar, et al.
Human Gene Therapy|July 8, 2005
Sustained phenotypic correction of canine hemophilia B after systemic administration of helper-dependent adenoviral vectorNicola Brunetti-Pierri, Timothy C Nichols, Stephanie McCorquodale, et al.
Immunology Letters|September 21, 2010
Adenoviral vectors stimulate innate immune responses in macrophages through cross-talk with epithelial cellsBenjamin H Lee, Rahul Kushwah, Jing Wu, et al.
Molecular Therapy. Nucleic Acids|October 12, 2016
Homology Requirements for Efficient, Footprintless Gene Editing at the CFTR Locus in Human iPSCs with Helper-dependent Adenoviral VectorsDonna J Palmer, Nathan C Grove, Jordan Ing, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent AdFrancesco Vetrini, Nicola Brunetti-Pierri, Donna J Palmer, et al.
Human Gene Therapy|February 7, 2009
Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia BNicola Brunetti-Pierri, Nathan C Grove, Yu Zuo, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Human Gene Therapy|February 18, 2004
Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primatesNicola Brunetti-Pierri, Donna J Palmer, Arthur L Beaudet, et al.
Human Gene Therapy|November 26, 2008
Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapySean E Hofherr, Julien S Senac, Christopher Y Chen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Viral vector-mediated and cell-based therapies for treatment of cystic fibrosisTerence R Flotte, Philip Ng, Doug E Dylla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2005
Fully deleted adenovirus persistently expressing GAA accomplishes long-term skeletal muscle glycogen correction in tolerant and nontolerant GSD-II miceAnne Kiang, Zachary C Hartman, Shaoxi Liao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2013
SR-A and SREC-I are Kupffer and endothelial cell receptors for helper-dependent adenoviral vectorsPasquale Piccolo, Francesco Vetrini, Pratibha Mithbaokar, et al.
Human Gene Therapy|July 8, 2005
Sustained phenotypic correction of canine hemophilia B after systemic administration of helper-dependent adenoviral vectorNicola Brunetti-Pierri, Timothy C Nichols, Stephanie McCorquodale, et al.
Immunology Letters|September 21, 2010
Adenoviral vectors stimulate innate immune responses in macrophages through cross-talk with epithelial cellsBenjamin H Lee, Rahul Kushwah, Jing Wu, et al.
Molecular Therapy. Nucleic Acids|October 12, 2016
Homology Requirements for Efficient, Footprintless Gene Editing at the CFTR Locus in Human iPSCs with Helper-dependent Adenoviral VectorsDonna J Palmer, Nathan C Grove, Jordan Ing, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2010
Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent AdFrancesco Vetrini, Nicola Brunetti-Pierri, Donna J Palmer, et al.
Human Gene Therapy|February 7, 2009
Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia BNicola Brunetti-Pierri, Nathan C Grove, Yu Zuo, et al.
Pageof 11